Carlos Federico Federico Molina Castaño

Dr. Carlos Federico Federico Molina Castaño

Tecnológico de Antioquia, Medellín, Antioquia, Colombia
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2022 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
JFJaime Fernández-Sarmiento
Jaime Fernández-Sarmiento
CCCarlos Federico Federico Molina Castaño
Carlos Federico Federico Molina Castaño
LSLina María Salazar-Pelaez
Lina María Salazar-Pelaez
SFSteffanie Flórez
Steffanie Flórez
LALaura Carolina Alarcón-Forero
Laura Carolina Alarcón-Forero
JVJuan Carlos Villar
Juan Carlos Villar
Objective: Sepsis is one of the main causes of morbidity and mortality worldwide. Microcirculatory impairment, especially damage to the endothelium and glycocalyx, is often not assessed. The objective of this systematic review and meta-analysis was to summarize the available evidence of the risk of unsatisfactory outcomes in patients with sepsis and elevated glycocalyx injury and endothelial activation biomarkers. Design: A systematic search was carried out on PubMed/MEDLINE, Embase, Cochrane and Google Scholar up to December 31, 2021, including studies in adults and children with sepsis which measured glycocalyx injury and endothelial activation biomarkers within 48 hours of hospital admission. The primary outcome was the risk of mortality from all causes and the secondary outcomes were the risk of developing respiratory failure (RF) and multiple organ dysfunction syndrome (MODS) in patients with elevations of these biomarkers. Measurements and Main Results: A total of 17 studies (3,529 patients) were included: 11 evaluated syndecan-1 (n=2,397) and 6 endocan (n=1,132). Syndecan-1 was higher in the group of patients who died than in those who survived [255 ng/mL (IQR: 139-305) vs. 83 ng/mL (IQR:40-111); p=0.014]. Patients with elevated syndecan-1 had a greater risk of death (OR 2.32; 95% CI 1.89, 3.10: p<0.001), MODS (OR 3.3; 95% CI 1.51, 7.25: p=0.003;), or RF (OR 7.53; 95% CI 1.86-30.45: p=0.005). Endocan was higher in patients who died [3.1 ng/mL (IQR 2.3, 3.7) vs. 1.62 ng/mL (IQR 1.2, 5.7); OR 9.53; 95% CI 3.34, 27.3; p<0.001], who had MODS (OR 8.33; 95% CI 2.07, 33.58; p=0.003) and who had RF (OR 9.66; 95% CI 2.26, 43.95; p=0.002). Conclusion: Patients with sepsis and abnormal glycocalyx injury and endothelial activation biomarkers have a greater risk of developing respiratory failure, multiple organ failure, and death. Microcirculatory impairment should be routinely evaluated in patients with sepsis, using biomarkers to stratify risk groups.

1 June 2022 in Burns
Verified
Journal Article
Closed access
ATAlejandra Tamayo-Gómez
Alejandra Tamayo-Gómez
JVJuliana Velásquez-Suárez
Juliana Velásquez-Suárez
LPLina Páramo-Duque
Lina Páramo-Duque
DODiana Ortiz-Carmona
Diana Ortiz-Carmona
LELina Escobar-Gómez
Lina Escobar-Gómez
CCCarlos Cardeno-Castro
Carlos Cardeno-Castro

16 March 2024 in Mine Water and the Environment
Verified
Journal Article
Closed access
PDF file
ARAndrés Montoya Rendón
Andrés Montoya Rendón
YJYaira Rueda Jiménez
Yaira Rueda Jiménez
COClementino Orejuela
Clementino Orejuela
CCCarlos Federico Federico Molina Castaño
Carlos Federico Federico Molina Castaño
FFFelipe Franco-Gaviria
Felipe Franco-Gaviria

24 October 2025 in Journal of Hazardous Materials
Verified
Journal Article
Open access
MRMirna Robledo-Moreno
Mirna Robledo-Moreno
CCCarlos Federico Federico Molina Castaño
Carlos Federico Federico Molina Castaño
CSCarlos Salazar-Camacho
Carlos Salazar-Camacho
MSManuel Salas-Moreno
Manuel Salas-Moreno
CRClelia Rosa Calao Ramos
Clelia Rosa Calao Ramos
SDSergi Díez
Sergi Díez
The Atrato River basin in western Colombia, one of the most biodiverse regions globally, faces severe mercury (Hg) contamination from artisanal gold mining. This study assessed the hematological effects of Hg exposure in 601 residents (aged 15-89 years) from four localities with different exposure levels. Blood mercury concentrations (HgB) were used to classify participants into high (HHgB >5.0 µg/L; n = 507) and low (LHgB <5.0 µg/L; n = 94) exposure groups. Alarmingly, the median HgB was 14.95 µg/L, and 84.3 % of samples exceeded the safety threshold of 5.0 µg/L. Males consistently showed higher HgB levels than females, particularly in adult and older age groups. Significant hematological alterations were observed in associations with Hg exposure. A considerable proportion of HHgB participants showed anemia: 14.7 % of young males and 21.2 % of young females had low hemoglobin; 6.9 % of adult males and 19.1 % of adult females had reduced hematocrit. Gender- and age-based differences were detected in multiple hematological parameters (HGB, HCT, RBC, MCHC, LYMPH, and PLT) measured using an Abbott Cell-Dyn Sapphire Analyzer, showing distinct patterns between HHgB and LHgB groups. Positive correlations were found between HgB and HGB or MCV in young males, and between HgB and neutrophils in young females with neutropenia, suggesting Hg-related disruption of red and white blood cell profiles. Comparisons between exposure groups also revealed differences in basophils, monocytes, and lymphocytes, especially among adults and olders. Despite regulations banning mercury use, continued exposure remains a major public health concern. These findings highlight the urgent need for targeted policies to strengthen enforcement of mercury regulations, increase monitoring, and implement community-based health interventions in gold mining regions.

24 April 2020 in Archivos de Medicina (Manizales)
Verified
Journal Article
Open access
PDF file
AHAndrea Juliana Gómez Hernández
Andrea Juliana Gómez Hernández
LVLina María Medina Vasquez
Lina María Medina Vasquez
CCCarlos Federico Federico Molina Castaño
Carlos Federico Federico Molina Castaño
JGJorge Humberto Botero Garcés
Jorge Humberto Botero Garcés
JÁJuan Carlos Alzate Ángel
Juan Carlos Alzate Ángel
Objetivo: determinar el efecto del cambio en la terapia antirretroviral sobre el control virológico en una cohorte de pacientes VIH positivos de una institución prestadora de servicios de salud en Medellín, Antioquia (Colombia)) en el año 2017. Materiales y métodos: estudio observacional analítico transversal, comparativo entre pacientes que cambiaron y no cambiaron el esquema inicial de terapia antirretroviral. Se realizó en una cohorte de 1245 pacientes que conviven con el VIH. Resultados: un total de 322 pacientes fueron evaluados. El principal motivo de cambio fue la presencia de efectos adversos a la terapia antirretroviral, seguido de la falla virológica sin genotipo e intolerancia a la terapia antirretroviral. La falla virológica, RP 1,4 IC95% (1,2-1,6, p 0,00), el tener genotipo, RP 1,2 IC95% (1,1-1,3, p 0,00) y el padecer una infección oportunista, RP 1,3 IC95% (1,0-1,6, p 0,03), se asociaron a mayor número de cambios a la TAR. La adherencia a la terapia antirretroviral, RP 0,18 IC95% (0,1-0,3, p 0,00) y la toma de otros medicamentos no relacionados al VIH (RP 0,6, IC95% 0,4-0,8, p 0,005) se asociaron a menor frecuencia de cambio de la terapia antirretroviral. El cambio de la terapia antirretroviral (OR ajustado 3,4, IC 95% (2,0-5,8), continúa siendo el factor pronóstico más importante para falla virológica. Conclusión: el cambio de la terapia antirretroviral, definida en este estudio como la principal variable de exposición, representa el principal factor de riesgo para falla virológica, incluso cuando fue ajustado por otras variables

16 October 2020 in Revista Colombiana de Cirugía
Verified
Journal Article
Open access
PDF file
NTNatalia Herrera Toro
Natalia Herrera Toro
LALaura Peña Aguirre
Laura Peña Aguirre
CCCarlos Federico Federico Molina Castaño
Carlos Federico Federico Molina Castaño
Introducción. El tumor de Wilms es el segundo tumor abdominal más frecuente en la edad pediátrica y responde por más del 90 % de los tumores renales en pediatría. A pesar de que la sobrevida descrita es mayor del 90 %, en nuestro medio encontramos que solo alcanza al 70 %, por lo que deseamos evaluar cuáles son los factores asociados con dichos resultados desfavorables, con el fin de implementar medidas para mejorar la sobrevida de nuestros pacientes. Métodos. Se realizó un estudio observacional, transversal, en dos centros de alto nivel de atención, que incluyó una muestra de 84 pacientes menores de 15 años, con diagnóstico de tumor de Wilms. Resultados. Los factores que se asociaron significativamente con un aumento en la probabilidad de morir fueron: no completar el protocolo de quimioterapia, (OR 34; IC95% 3,7-312; p 0,000) y presentar recidiva tumoral (OR 35,7; IC95% 6,9-184; p 0,000). Otros factores que aumentaron esta probabilidad sin alcanzar a ser significativos, pero mostrando una evidente tendencia fueron: presentación bilateral (OR 4,1; IC95% 0,6-5,5; p 0,147), complicaciones quirúrgicas (OR 3,2; IC95% 0,7-14,6; p 0,136), compromiso de ganglios linfáticos en tomografía (OR 2,4; IC95% 0,7-8,4; p 0,139) y las metástasis a distancia (OR 2,5; IC95% 0,7-9; p 0,143). Discusión. La sobrevida de nuestros niños con tumor de Wilms es menor que la reportada en la literatura mundial, siendo la falla en terminar la quimioterapia, la recidiva y la necesidad de cirugía bilateral, los factores asociados con este desenlace.